Practical AI for CEOs


The AI race is on. CEOs recognise it as the new force multiplier. AI has the potential to both reshape productivity and drive commercial effectiveness. This report by Criticaleye Partner AlixPartners provides a guide to help manage an array of competing stakeholder demands and develop your understanding and capabilities.
 
Key Takeaways Include:
  • Your data is one of your most valuable assets - make it work for you.
  • A fear of missing out and a herd mentality can disproportionately influence technology investments in the current market, potentially leading to poor returns.
  • Deep experience in dealing with business problems, combined with AI insights, drives the kind of actionable results that customers demand.

Share this with your Community





Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

BLOG | The CEO-CFO Partnership: Driving Strategic Alignment

The relationship between the CEO and CFO has never been more important.  In a business environment defined by economic uncertainty, AI-driven transformation and heightened stakeholder expe...


Click here to download this insight

Building an AI-Ready Workforce

AI is reshaping ways of working faster than most organisations can adapt, putting talent strategy at the top of the Board agenda. Criticaleye's Anna Mitchell asks Board Leaders and CPOs with hands-on experience o...


Click here to download this insight

Driving the Next Phase of Growth at RAC

In this interview with Criticaleye Senior Editor Jacob Ambrose Willson, RAC’s CFO, Jo Baker, talks through how she has helped to steer the business through a significant transformation during the last several year...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 227




Hitachi Solutions E.ON UK LACE Partners Rolls-Royce Legal & General Drax Group plc Stream Southern Water British Land Global Payments NatWest Group NATS Lightsource bp London Stock Exchange Group Mayborn Group AlixPartners GlaxoSmithKline plc